[go: up one dir, main page]

WO2009006299A3 - Multi-particulate systems - Google Patents

Multi-particulate systems Download PDF

Info

Publication number
WO2009006299A3
WO2009006299A3 PCT/US2008/068574 US2008068574W WO2009006299A3 WO 2009006299 A3 WO2009006299 A3 WO 2009006299A3 US 2008068574 W US2008068574 W US 2008068574W WO 2009006299 A3 WO2009006299 A3 WO 2009006299A3
Authority
WO
WIPO (PCT)
Prior art keywords
particulate systems
particles
substance
coated
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/068574
Other languages
French (fr)
Other versions
WO2009006299A2 (en
Inventor
Venkateswarlu Vobalaboina
Ezhil Arasan Ramanan
Venkat Arvind Vakati
Deshpande Mangesh
Nookaraju Venkata Sreedharala
Sarveswara Rao Srirama Mandavilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of WO2009006299A2 publication Critical patent/WO2009006299A2/en
Publication of WO2009006299A3 publication Critical patent/WO2009006299A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oral pharmaceutical compositions comprising a plurality of particles comprising an active ingredient, wherein the particles are coated with or contain a bioadhesive component and have outer coatings comprising a substance that dissolves under predetermined pH conditions.
PCT/US2008/068574 2007-06-29 2008-06-27 Multi-particulate systems Ceased WO2009006299A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94702007P 2007-06-29 2007-06-29
US60/947,020 2007-06-29
US95000007P 2007-07-16 2007-07-16
US60/950,000 2007-07-16

Publications (2)

Publication Number Publication Date
WO2009006299A2 WO2009006299A2 (en) 2009-01-08
WO2009006299A3 true WO2009006299A3 (en) 2009-02-19

Family

ID=40226782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/068574 Ceased WO2009006299A2 (en) 2007-06-29 2008-06-27 Multi-particulate systems

Country Status (1)

Country Link
WO (1) WO2009006299A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2558120A4 (en) 2010-04-15 2013-08-28 Shin Nippon Biomedical Lab Ltd METHODS AND COMPOSITIONS FOR INTRANASAL DELIVERY
CN103565751A (en) * 2013-10-17 2014-02-12 广州帝奇医药技术有限公司 Long-acting sustained-release pellet and preparation method thereof
JP6339800B2 (en) * 2013-12-27 2018-06-06 株式会社三和化学研究所 Miglitol-containing coating formulation
EP4062907A1 (en) * 2021-03-23 2022-09-28 Substipharm Formulation for oral administration of ivermectin and uses thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
WO2001052816A2 (en) * 2000-01-19 2001-07-26 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
WO2004045589A1 (en) * 2002-11-15 2004-06-03 Elan Pharmaceuticals, Inc. Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
WO2005044240A2 (en) * 2003-10-31 2005-05-19 Dexcel, Ltd. Stable lansoprazole formulation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003670A1 (en) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Paroxetine controlled release compositions
WO2001052816A2 (en) * 2000-01-19 2001-07-26 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
WO2004045589A1 (en) * 2002-11-15 2004-06-03 Elan Pharmaceuticals, Inc. Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
WO2005044240A2 (en) * 2003-10-31 2005-05-19 Dexcel, Ltd. Stable lansoprazole formulation

Also Published As

Publication number Publication date
WO2009006299A2 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
WO2006104894A3 (en) Coating for implantable devices and a method of forming the same
WO2005101983A3 (en) Gastric retention system
EP3967695A4 (en) Quinazoline compound and pharmaceutical application thereof
WO2006008739A3 (en) Modified conductive surfaces having active substances attached thereto
WO2008132712A3 (en) Combination pharmaceutical compositions
WO2012022919A3 (en) Nalbuphine-based formulations and uses thereof
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
EP2177235A3 (en) Coating compositions
WO2009048645A3 (en) Lipid coatings for implantable medical devices
WO2005053571A3 (en) Biobeneficial coating compositions and methods of making and using thereof
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
WO2006084164A3 (en) Gastric retention and controlled release delivery system
ATE515260T1 (en) STABLE NANOCAPSULE SYSTEMS FOR THE ADMINISTRATION OF ACTIVE INGREDIENTS
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2006099514A3 (en) Drug delivery compositions and related methods
WO2008042748A3 (en) Polyelectrolyte media for bioactive agent delivery
WO2009019477A3 (en) Coating
WO2009106824A3 (en) Pharmaceutical formulations with a taste masking coating
EP2180024A4 (en) Hydrophilic film-forming composition, spray composition, and hydrophilic member using the same
WO2009121970A3 (en) Coating material
WO2009154810A3 (en) Delivery systems for multiple active agents
EP3694331A4 (en) Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
MX2009008197A (en) Extended-release dosage form.
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08772161

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 7392/CHENP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08772161

Country of ref document: EP

Kind code of ref document: A2